APA (7th ed.) Citation

Karateev, A. E., Polishchuk, E. Y., Potapova, A. S., Matyanova, E. V., Semashko, A. S., Bobkova, А. O., . . . Lila, A. M. (2022). The use of biological disease-modifying antirheumatic drugs and Janus kinase inhibitors in rheumatoid arthritis during the COVID-19 coronavirus disease pandemic: Data from a telephone survey of 254 patients. IMA PRESS LLC.

Chicago Style (17th ed.) Citation

Karateev, A. E., et al. The Use of Biological Disease-modifying Antirheumatic Drugs and Janus Kinase Inhibitors in Rheumatoid Arthritis During the COVID-19 Coronavirus Disease Pandemic: Data from a Telephone Survey of 254 Patients. IMA PRESS LLC, 2022.

MLA (9th ed.) Citation

Karateev, A. E., et al. The Use of Biological Disease-modifying Antirheumatic Drugs and Janus Kinase Inhibitors in Rheumatoid Arthritis During the COVID-19 Coronavirus Disease Pandemic: Data from a Telephone Survey of 254 Patients. IMA PRESS LLC, 2022.